Clinical Trial Update: Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preoperative chemotherapy for patients with early triple-negative breast cancer or HER2-positive operable breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN